Dawn Svoronos

Insider Reports History

Location
C/O Medivation, Inc., 525 Market St., 36 Th Floor, San Francisco, CA
Signature
/s/ Aneta Fergson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dawn Svoronos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PTC THERAPEUTICS, INC. Director Common Stock 29K $794K $27.38 Jun 9, 2022 Direct
PTC THERAPEUTICS, INC. Director Stock Option (Right To Buy) 12K $325K $27.05 Jan 7, 2022 Direct
ACELYRIN, Inc. Director Common Stock 0 $0 $2.45 May 21, 2025 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17K Jun 5, 2025 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 10.5K Jun 17, 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2.65K Jun 5, 2025 Direct
ACELYRIN, Inc. Director Director Stock Option (right to buy) 0 May 21, 2025 Direct
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by Dawn Svoronos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADVM Adverum Biotechnologies, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2025 2 $0 4 Jun 6, 2025 Director
SLRN ACELYRIN, Inc. May 21, 2025 4 $0 4 May 23, 2025 Director
ADVM Adverum Biotechnologies, Inc. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
SLRN ACELYRIN, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XENE Xenon Pharmaceuticals Inc. Aug 24, 2023 1 -$968K 4 Aug 24, 2023 Director
ADVM Adverum Biotechnologies, Inc. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
XENE Xenon Pharmaceuticals Inc. Jun 2, 2023 1 $0 4 Jun 2, 2023 Director
SLRN ACELYRIN, Inc. May 9, 2023 5 $270K 4 May 11, 2023 Director
SLRN ACELYRIN, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director
SLRN ACELYRIN, Inc. May 4, 2023 0 $0 3 May 4, 2023 Director
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 7 $0 4 Oct 6, 2022 Director
XENE Xenon Pharmaceuticals Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 21, 2022 1 -$52K 4 Jun 22, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 14, 2022 4 $0 4 Jun 16, 2022 Director
ADVM Adverum Biotechnologies, Inc. Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
PTCT PTC THERAPEUTICS, INC. Jun 9, 2022 1 -$20.1K 4 Jun 10, 2022 Director
ADVM Adverum Biotechnologies, Inc. May 16, 2022 1 $25.6K 4 May 18, 2022 Director
PTCT PTC THERAPEUTICS, INC. Jan 7, 2022 3 -$19.6K 4 Jan 11, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 17, 2021 5 -$58.8K 4 Jun 21, 2021 Director
PTCT PTC THERAPEUTICS, INC. Jun 9, 2021 1 -$15.3K 4 Jun 11, 2021 Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Director
ADVM Adverum Biotechnologies, Inc. May 12, 2021 1 $0 4 May 14, 2021 Director